# SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study

> **NCT00590564** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 42 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sho-saiko-to

## Key facts

- **NCT ID:** NCT00590564
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590564, "SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00590564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*